Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAlessandra Barbanente, Anna Maria Di Cosola, Luisa Curlacci, Pierluigi Lasala, Valentina Gandin, Matteo Forner, Nicola Margiotta
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Metallodrugs are unique: opportunities and challenges of discovery and development
10.1039/d0sc04082g · 2020
Antitumour metal compounds: more than theme and variations
10.1039/b712656p · 2008
Inhibition of transcription by platinum antitumor compounds
10.1039/b907567d · 2009
Platinum(IV) anticancer prodrugs - hypotheses and facts
10.1039/c6dt01414c · 2016
Recent developments in the field of anticancer platinum complexes
10.2174/157489206777442287 · 2006
Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches
10.2174/0929867054637626 · 2005
Targeting and delivery of platinum-based anticancer drugs
10.1039/c2cs35259a · 2013
Pt(II) and Pt(IV) complexes with a major component of royal jelly as innovative antitumor drug candidates
10.1039/d3nj03617k · 2023
Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models
10.1016/j.cbi.2025.111792 · 2026
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
datacite
Confidence 0%
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model
10.1016/j.nbd.2018.12.007 · 2019
The occurrence, metabolism and toxicity of cinnamic acid and related compounds
10.1002/jat.2550040602 · 1984
Cinnamic acid and cinnamaldehyde ameliorate cisplatin-induced splenotoxicity in rats
10.1002/jbt.21715 · 2015
Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties
10.1016/j.bioorg.2019.102951 · 2019
Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2
10.1016/j.lfs.2019.116819 · 2019
Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin
10.1016/j.biocel.2008.01.031 · 2008
Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells
10.1016/s0304-3835(98)00073-1 · 1998
Cinnamic acid: a natural product with potential use in cancer intervention
10.1002/ijc.2910620319 · 1995
Platinum (IV) derivatives with cinnamate axial ligands as potent agents against both differentiated and tumorigenic cancer stem rhabdomyosarcoma cells
10.1002/anie.201913996 · 2020
A multi-action Pt IV conjugate with oleate and cinnamate ligands targets human epithelial growth factor receptor HER2 in aggressive breast cancer cells
10.1002/ange.202009491 · 2020
Platinum(II) O,S complexes inhibit the aggregation of amyloid model systems
10.3390/ijms20040829 · 2019
Comments on different synthetic methods for the preparation of diammine and bis(amine) organodicarboxylatoplatinum(II) complexes
10.1080/15533179308016879 · 1993
New oxaliplatin-pyrophosphato analogs with improved in vitro cytotoxicity
10.3390/molecules26113417 · 2021
Easily available, amphiphilic diiron cyclopentadienyl complexes exhibit in vitro anticancer activity in 2D and 3D human cancer cells through redox modulation triggered by CO release
2021
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: prodrugs affording an oxaliplatin analogue that overcomes cancer resistance
10.3390/ijms21072325 · 2020
Platinum-195 nuclear magnetic resonance
10.1016/s0010-8545(00)80523-8 · 1982
Interactions with DNA models of the oxaliplatin analog (cis-1,3-DACH)PtCl2
10.3390/ijms25137392 · 2024
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
10.1039/c9ra07760j · 2019
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum—carbon bond formation
10.1016/0162-0134(91)84038-b · 1991
Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives
10.1016/j.ejmech.2017.04.007 · 2017
Platinum, palladium, gold and ruthenium complexes as anticancer agents: current clinical uses, cytotoxicity studies and future perspectives
10.1016/j.ejmech.2017.04.007 · doi-reference
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato)platinum(II). Evidence for a novel rearrangement involving platinum—carbon bond formation
10.1016/0162-0134(91)84038-b · doi-reference
A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring
10.1039/c9ra07760j · doi-reference
Interactions with DNA models of the oxaliplatin analog (cis-1,3-DACH)PtCl2
10.3390/ijms25137392 · doi-reference
Platinum-195 nuclear magnetic resonance
10.1016/s0010-8545(00)80523-8 · doi-reference
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: prodrugs affording an oxaliplatin analogue that overcomes cancer resistance
10.3390/ijms21072325 · doi-reference
New oxaliplatin-pyrophosphato analogs with improved in vitro cytotoxicity
10.3390/molecules26113417 · doi-reference
Comments on different synthetic methods for the preparation of diammine and bis(amine) organodicarboxylatoplatinum(II) complexes
10.1080/15533179308016879 · doi-reference
Platinum(II) O,S complexes inhibit the aggregation of amyloid model systems
10.3390/ijms20040829 · doi-reference
A multi-action Pt IV conjugate with oleate and cinnamate ligands targets human epithelial growth factor receptor HER2 in aggressive breast cancer cells
10.1002/ange.202009491 · doi-reference
Platinum (IV) derivatives with cinnamate axial ligands as potent agents against both differentiated and tumorigenic cancer stem rhabdomyosarcoma cells
10.1002/anie.201913996 · doi-reference
Cinnamic acid: a natural product with potential use in cancer intervention
10.1002/ijc.2910620319 · doi-reference
Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2 cells
10.1016/s0304-3835(98)00073-1 · doi-reference
Anticancer effects of ginsenoside Rg1, cinnamic acid, and tanshinone IIA in osteosarcoma MG-63 cells: nuclear matrix downregulation and cytoplasmic trafficking of nucleophosmin
10.1016/j.biocel.2008.01.031 · doi-reference
Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2
10.1016/j.lfs.2019.116819 · doi-reference
Design and synthesis of the novel oleanolic acid-cinnamic acid ester derivatives and glycyrrhetinic acid-cinnamic acid ester derivatives with cytotoxic properties
10.1016/j.bioorg.2019.102951 · doi-reference
Cinnamic acid and cinnamaldehyde ameliorate cisplatin-induced splenotoxicity in rats
10.1002/jbt.21715 · doi-reference
The occurrence, metabolism and toxicity of cinnamic acid and related compounds
10.1002/jat.2550040602 · doi-reference
Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model
10.1016/j.nbd.2018.12.007 · doi-reference
Platinum(IV) oxaliplatin analog containing axial benzoate ligands induces mitochondrial hyperpolarization and caspase-dependent apoptosis in pancreatic cancer cell models
10.1016/j.cbi.2025.111792 · doi-reference
Pt(II) and Pt(IV) complexes with a major component of royal jelly as innovative antitumor drug candidates
10.1039/d3nj03617k · doi-reference
Targeting and delivery of platinum-based anticancer drugs
10.1039/c2cs35259a · doi-reference
Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches
10.2174/0929867054637626 · doi-reference
Recent developments in the field of anticancer platinum complexes
10.2174/157489206777442287 · doi-reference
Platinum(IV) anticancer prodrugs - hypotheses and facts
10.1039/c6dt01414c · doi-reference
Inhibition of transcription by platinum antitumor compounds
10.1039/b907567d · doi-reference
Antitumour metal compounds: more than theme and variations
10.1039/b712656p · doi-reference
Metallodrugs are unique: opportunities and challenges of discovery and development
10.1039/d0sc04082g · doi-reference